Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite

Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant

By Wu H.-Y.   Russell M.W.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 286-292

Elsevier

Access to resources Recommend Favorite

Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

By Isaka M.   Yasuda Y.   Kozuka S.   Miura Y.   Taniguchi T.   Matano K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 16, Iss. 17, 1998-10 ,pp. : 1620-1626

Elsevier

Access to resources Recommend Favorite

Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate

By Shen X.   Lagergard T.   Yang Y.   Lindblad M.   Fredriksson M.   Wallerstrom G.   Holmgren J.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3360-3368

Elsevier

Access to resources Recommend Favorite

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies

By Yasuda Y.   Isaka M.   Taniguchi T.   Zhao Y.   Matano K.   Matsui H.   Morokuma K.   Maeyama J.-i.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2954-2963

Elsevier

Access to resources Recommend Favorite